Joseph Emil Amegadzie

7PUBLICATIONS
11CO-AUTHORS
Time-series analysisRespiratory diseasesLearning, motivation and emotionPredictive and prognostic markersBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 28, 2024
20-year trends in excess costs of COPD.

Joseph Emil Amegadzie, Jeenat Mehareen, Amir Khakban

|Dec 05, 2023
QRISK3 underestimates the risk of cardiovascular events in patients with COPD.

Joseph Emil Amegadzie, Zhiwei Gao, Jennifer K Quint

|Aug 31, 2023
A long overdue recognition: COPD as a distinct predictor of cardiovascular disease risk.

Joseph Emil Amegadzie, Mohsen Sadatsafavi

|Jun 01, 2022
Association between Inhaled β2-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control Study.

Joseph Emil Amegadzie, John-Michael Gamble, Jamie Farrell

|Oct 16, 2020
Gender Differences in Inhaled Pharmacotherapy Utilization in Patients with Obstructive Airway Diseases (OADs): A Population-Based Study.

Joseph Emil Amegadzie, John-Michael Gamble, Jamie Farrell

|Nov 01, 2019
Comparative safety and effectiveness of inhaled bronchodilators and corticosteroids for treating asthma-COPD overlap: a systematic review and meta-analysis.

Joseph Emil Amegadzie, Jessica Gorgui, Lily Acheampong

Pageof 2